News Releases

01 Feb '22
Christopher Lowe appointed interim chief executive officer David Lamond named chairman of the board SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 1, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, today
Displaying 21 - 22 of 22